Cortisom 1.0
Natural health product licensed in Canada
- Licence holder
- ATP ATHLÉTIQUE ET THÉRAPEUTIQUE PHARMA INC. ou ATP ATHLETIC AND THERAPEUTIC PHARMA INC.
- NPN or DIN-HM
- 80072477
- Status
- Inactive licence
- Licence date
- 12 September 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Magnésium: up to 400 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 6 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 400 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Scutellaria lateriflora Source : Sommité | 50 milligramme | Not calculated |
| Scutellaria baicalensis Source : Racine Extract : Matériel brut sec Extraction ratio : 6:1 Dry plant equivalent : 150 milligramme | 25 milligramme | Not calculated |
| Eschscholzia californica Source : Sommité | 75 milligramme | Not calculated |
| N-[2-(5-méthoxy-1H-indol-3-yl)éthyl]acétamide Source : Mélatonine | 0.25 milligramme | Not calculated |
| Magnésium Source : Glycinate de magnésium | 100 milligramme | 400,000 µg |
| Vitamine B6 Source : 5-phosphate de pyridoxal | 1.5 milligramme | 6,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, L-Leucine, Extrait de Fleur/Feuilles/Tige de Lavandula Angustifolia (Lavande), Farine de riz brun, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Scutellaria lateriflora (Skullcap) is traditionally used in Herbal Medicine to help relieve nervousness (calmative/sedative). Scutellaria lateriflora (Skullcap) is traditionally used in Herbal Medicine as a sleep aid (in cases of restlessness or insomnia due to stress). Scutellaria lateriflora (Skullcap) is traditionally used in Herbal Medicine to help relieve the pain associated with menstruation (antispasmodic). Eschscholzia californica (California-poppy) is traditionally used in Herbal Medicine as a mild sedative and/or sleep aid (hypnotic). Eschscholzia californica (California-poppy) is traditionally used in Herbal Medicine as an analgesic. Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule. Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder. Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Helps in energy metabolism, tissue formation and bone development.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consumption with alcohol, other drugs and/or natural health products with sedative properties is not recommended. Consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks (chronic insomnia). If you are taking prescription medications, consult a health care practitioner prior to use. If you have one of the following conditions, consult a health care practitioner prior to use: asthma, cardiovascular disease, chronic kidney disease, depression, diabetes or hypoglycaemia, hormonal disorder, immune system disease, liver disease, migraine, or seizure disorders.
- Effets indésirables connus
Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. Mild gastrointestinal symptoms (nausea, vomiting, or cramping) have been known to occur in which case, discontinue use. Some people may experience diarrhoea. Rare allergic reactions have been known to occur in which case, discontinue use.
Source
Official Health Canada record, licence 80072477
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.